Variations in primary sclerosing cholangitis across the age spectrum

John E. Eaton, Bryan M. McCauley, Elizabeth J. Atkinson, Brian D. Juran, Erik M. Schlicht, Mariza De Andrade, Konstantinos N Lazaridis

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background and Aim: Primary sclerosing cholangitis (PSC) typically develops in middle-age adults. Little is known about phenotypic differences when PSC is diagnosed at various ages. Therefore, we sought to compare the clinical characteristics of a large PSC cohort based on the age when PSC was diagnosed. Methods: We performed a multicenter retrospective review to compare the features of PSC among those diagnosed between 1–19 (n = 95), 20–59 (n = 662), and 60–79 years (n = 102). Results: Those with an early diagnosis (ED) of PSC were more likely to have small-duct PSC (13%) than those with a middle-age diagnosis (MD) (5%) and late diagnosis (LD) groups (2%), P < 0.01, and appeared to have a decrease risk of hepatobiliary malignancies: ED versus MD: hazard ratio (HR), 0.25; 95% confidence interval (CI) 0.06–1.03, and ED versus LD: HR, 0.07; 95% CI 0.01–0.62. Cholangiocarcinoma was diagnosed in 78 subjects (ED n = 0, MD n = 66, and LD n = 12) and was more likely to be diagnosed within a year after the PSC diagnosis among those found to have PSC late in life: ED 0% (0/95), MD 2% (14/662), and LD 6% (6/102), P = 0.02. Similarly, hepatic decompensation was more common among those with LD-PSC versus younger individuals: LD versus MD: HR, 1.64; 95% CI 0.98–2.70, and LD versus ED: HR, 2.26; 95% CI 1.02–5.05. Conclusions: Those diagnosed with PSC early in life are more likely to have small-duct PSC and less likely to have disease-related complications. Clinicians should be vigilant for underlying cholangiocarcinoma among those with PSC diagnosed late in life.

Original languageEnglish (US)
Pages (from-to)1763-1768
Number of pages6
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume32
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Sclerosing Cholangitis
Delayed Diagnosis
Early Diagnosis
Confidence Intervals
Cholangiocarcinoma

Keywords

  • cholangiocarcinoma
  • inflammatory bowel disease
  • liver transplantation
  • primary sclerosing cholangitis

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Variations in primary sclerosing cholangitis across the age spectrum. / Eaton, John E.; McCauley, Bryan M.; Atkinson, Elizabeth J.; Juran, Brian D.; Schlicht, Erik M.; De Andrade, Mariza; Lazaridis, Konstantinos N.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 32, No. 10, 01.10.2017, p. 1763-1768.

Research output: Contribution to journalArticle

Eaton, John E. ; McCauley, Bryan M. ; Atkinson, Elizabeth J. ; Juran, Brian D. ; Schlicht, Erik M. ; De Andrade, Mariza ; Lazaridis, Konstantinos N. / Variations in primary sclerosing cholangitis across the age spectrum. In: Journal of Gastroenterology and Hepatology (Australia). 2017 ; Vol. 32, No. 10. pp. 1763-1768.
@article{3c100e152c284f649af2d7b795186d2d,
title = "Variations in primary sclerosing cholangitis across the age spectrum",
abstract = "Background and Aim: Primary sclerosing cholangitis (PSC) typically develops in middle-age adults. Little is known about phenotypic differences when PSC is diagnosed at various ages. Therefore, we sought to compare the clinical characteristics of a large PSC cohort based on the age when PSC was diagnosed. Methods: We performed a multicenter retrospective review to compare the features of PSC among those diagnosed between 1–19 (n = 95), 20–59 (n = 662), and 60–79 years (n = 102). Results: Those with an early diagnosis (ED) of PSC were more likely to have small-duct PSC (13{\%}) than those with a middle-age diagnosis (MD) (5{\%}) and late diagnosis (LD) groups (2{\%}), P < 0.01, and appeared to have a decrease risk of hepatobiliary malignancies: ED versus MD: hazard ratio (HR), 0.25; 95{\%} confidence interval (CI) 0.06–1.03, and ED versus LD: HR, 0.07; 95{\%} CI 0.01–0.62. Cholangiocarcinoma was diagnosed in 78 subjects (ED n = 0, MD n = 66, and LD n = 12) and was more likely to be diagnosed within a year after the PSC diagnosis among those found to have PSC late in life: ED 0{\%} (0/95), MD 2{\%} (14/662), and LD 6{\%} (6/102), P = 0.02. Similarly, hepatic decompensation was more common among those with LD-PSC versus younger individuals: LD versus MD: HR, 1.64; 95{\%} CI 0.98–2.70, and LD versus ED: HR, 2.26; 95{\%} CI 1.02–5.05. Conclusions: Those diagnosed with PSC early in life are more likely to have small-duct PSC and less likely to have disease-related complications. Clinicians should be vigilant for underlying cholangiocarcinoma among those with PSC diagnosed late in life.",
keywords = "cholangiocarcinoma, inflammatory bowel disease, liver transplantation, primary sclerosing cholangitis",
author = "Eaton, {John E.} and McCauley, {Bryan M.} and Atkinson, {Elizabeth J.} and Juran, {Brian D.} and Schlicht, {Erik M.} and {De Andrade}, Mariza and Lazaridis, {Konstantinos N}",
year = "2017",
month = "10",
day = "1",
doi = "10.1111/jgh.13774",
language = "English (US)",
volume = "32",
pages = "1763--1768",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Variations in primary sclerosing cholangitis across the age spectrum

AU - Eaton, John E.

AU - McCauley, Bryan M.

AU - Atkinson, Elizabeth J.

AU - Juran, Brian D.

AU - Schlicht, Erik M.

AU - De Andrade, Mariza

AU - Lazaridis, Konstantinos N

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Background and Aim: Primary sclerosing cholangitis (PSC) typically develops in middle-age adults. Little is known about phenotypic differences when PSC is diagnosed at various ages. Therefore, we sought to compare the clinical characteristics of a large PSC cohort based on the age when PSC was diagnosed. Methods: We performed a multicenter retrospective review to compare the features of PSC among those diagnosed between 1–19 (n = 95), 20–59 (n = 662), and 60–79 years (n = 102). Results: Those with an early diagnosis (ED) of PSC were more likely to have small-duct PSC (13%) than those with a middle-age diagnosis (MD) (5%) and late diagnosis (LD) groups (2%), P < 0.01, and appeared to have a decrease risk of hepatobiliary malignancies: ED versus MD: hazard ratio (HR), 0.25; 95% confidence interval (CI) 0.06–1.03, and ED versus LD: HR, 0.07; 95% CI 0.01–0.62. Cholangiocarcinoma was diagnosed in 78 subjects (ED n = 0, MD n = 66, and LD n = 12) and was more likely to be diagnosed within a year after the PSC diagnosis among those found to have PSC late in life: ED 0% (0/95), MD 2% (14/662), and LD 6% (6/102), P = 0.02. Similarly, hepatic decompensation was more common among those with LD-PSC versus younger individuals: LD versus MD: HR, 1.64; 95% CI 0.98–2.70, and LD versus ED: HR, 2.26; 95% CI 1.02–5.05. Conclusions: Those diagnosed with PSC early in life are more likely to have small-duct PSC and less likely to have disease-related complications. Clinicians should be vigilant for underlying cholangiocarcinoma among those with PSC diagnosed late in life.

AB - Background and Aim: Primary sclerosing cholangitis (PSC) typically develops in middle-age adults. Little is known about phenotypic differences when PSC is diagnosed at various ages. Therefore, we sought to compare the clinical characteristics of a large PSC cohort based on the age when PSC was diagnosed. Methods: We performed a multicenter retrospective review to compare the features of PSC among those diagnosed between 1–19 (n = 95), 20–59 (n = 662), and 60–79 years (n = 102). Results: Those with an early diagnosis (ED) of PSC were more likely to have small-duct PSC (13%) than those with a middle-age diagnosis (MD) (5%) and late diagnosis (LD) groups (2%), P < 0.01, and appeared to have a decrease risk of hepatobiliary malignancies: ED versus MD: hazard ratio (HR), 0.25; 95% confidence interval (CI) 0.06–1.03, and ED versus LD: HR, 0.07; 95% CI 0.01–0.62. Cholangiocarcinoma was diagnosed in 78 subjects (ED n = 0, MD n = 66, and LD n = 12) and was more likely to be diagnosed within a year after the PSC diagnosis among those found to have PSC late in life: ED 0% (0/95), MD 2% (14/662), and LD 6% (6/102), P = 0.02. Similarly, hepatic decompensation was more common among those with LD-PSC versus younger individuals: LD versus MD: HR, 1.64; 95% CI 0.98–2.70, and LD versus ED: HR, 2.26; 95% CI 1.02–5.05. Conclusions: Those diagnosed with PSC early in life are more likely to have small-duct PSC and less likely to have disease-related complications. Clinicians should be vigilant for underlying cholangiocarcinoma among those with PSC diagnosed late in life.

KW - cholangiocarcinoma

KW - inflammatory bowel disease

KW - liver transplantation

KW - primary sclerosing cholangitis

UR - http://www.scopus.com/inward/record.url?scp=85029917413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029917413&partnerID=8YFLogxK

U2 - 10.1111/jgh.13774

DO - 10.1111/jgh.13774

M3 - Article

C2 - 28245345

AN - SCOPUS:85029917413

VL - 32

SP - 1763

EP - 1768

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 10

ER -